Blog
RSS FeedPosted by Michael Wonder on 05 Sep 2019
$32 million available to support vital translational health
5 September 2019 - The Australian Government is opening the door for Australian researchers through a $32 million investment that will ...
Posted by Michael Wonder on 21 Aug 2019
Chinese stealing health and medical research data: report
21 August 2019 - The global healthcare sector, including Australia, faces increasing cyber threats and malicious activity from Chinese groups, ...
Posted by Michael Wonder on 22 Jun 2019
Azar's plan to tie U.S. drug prices to foreign ones will impact investments in R&D
21 June 2019 - Americans, be they Republicans or Democrats, are outraged by the rising cost of prescription drugs. ...
Posted by Michael Wonder on 05 Jun 2019
Pharma groups combine to promote drug discovery with AI
5 June 2019 - Blockchain system allows companies to share data without revealing commercial secrets. ...
Posted by Michael Wonder on 14 May 2019
A new study sparks a war of words over the drug industry’s commitment to research
14 May 2019 - The pharmaceutical industry spends about $1 in $5 of its revenues on research and development. ...
Posted by Michael Wonder on 08 May 2019
Medicines Australia welcomes ALP R&D investment pledge
8 May 2019 - Medicines Australia welcomes today’s announcement from the Australian Labor Party to reform the Research and Development ...
Posted by Michael Wonder on 26 Mar 2019
$65 million to unlock the potential of personalised medicine through genomics
26 March 2019 - The Australian Government will provide over $65 million in competitive research grants to Australia’s best and brightest ...
Posted by Michael Wonder on 17 Mar 2019
On the use of list prices in drug pricing research
14 March 2019 - In the limitations section of this article, we discussed in detail that list prices do not capture ...
Posted by Michael Wonder on 23 Jan 2019
Citizens ask - scientists answer: the IQWiG sets four new topics for HTA reports
23 January 2019 - Citizens, patients and medical experts: selection of topics with a sense of proportion ...
Posted by Michael Wonder on 21 Jan 2019
China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs
19 January 2019 - New policy environment demanding cheaper drugs adds pressure to innovate. ...
Posted by Michael Wonder on 03 Dec 2018
Canadian R&D-to-sales ratio for brand-name drug companies less than half of 10% commitment
3 December 2018 - USMCA concessions latest hit to Canadian prescription drug costs. ...
Posted by Michael Wonder on 08 Oct 2018
Request for proposals for PHARMAC and HRC research partnership 2019
8 October 2018 - PHARMAC and the Health Research Council of New Zealand request research proposals. ...
Posted by Michael Wonder on 09 Aug 2018
Americans fund most of the world’s drug research. Here’s how Trump can end that.
9 August 2018 - President Donald Trump recently released an ambitious, 44-page plan to drive down prescription drug prices. The ...
Posted by Michael Wonder on 09 Jun 2018
Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005
6 June 2018 - Well conducted clinical trials are widely regarded as the best source of evidence on the efficacy and ...
Posted by Michael Wonder on 06 Jun 2018
Big pharma wants to invest more in Australian biotech says Greg Hunt
6 June 2018 - Big pharma is "looking at Australia as the next destination in the developed world, the emerging first-world ...